Skip to main navigation Skip to search Skip to main content

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a " standard chemotherapy regimen" : The CASA randomized trial

  • D. Crivellari
  • , K.P. Gray
  • , S. Dellapasqua
  • , F. Puglisi
  • , K. Ribi
  • , K.N. Price
  • , I. Láng
  • , L. Gianni
  • , S. Spazzapan
  • , G. Pinotti
  • , J.-M. Lüthi
  • , R.D. Gelber
  • , M.M. Regan
  • , M. Colleoni
  • , M. Castiglione-Gertsch
  • , R. Maibach
  • , M. Rabaglio
  • , A.S. Coates
  • , A. Goldhirsch

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)130-137
Number of pages8
JournalBreast
Volume22
Issue number2
Publication statusPublished - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this